Key Highlights
● Stryker rose with no confirmed company-specific news, moving in step with other medical-device makers.
● Abbott and Intuitive Surgical also climbed, while life-science tools stocks rallied separately.
● Big drugmakers dragged on health care: Merck was the Dow's worst performer.
Stryker rose on Monday, Oct. 5, as medical-device makers advanced together and outperformed a health care sector weighed down by big drugmakers.
Devices in demand
Stryker (NYSE:SYK) rose on Monday, according to market data, ending the session among the gainers in the S&P 500.
Stryker moved in step with other medical-technology companies. Abbott Laboratories (NYSE:ABT) and Intuitive Surgical (NASDAQ:ISRG) also climbed, giving the MedTech group a solid day even as health care overall slipped.
Who Stryker is
Stryker is one of the world's biggest medical-device companies. It makes orthopaedic implants such as replacement hips and knees, surgical equipment and robotic systems used in joint replacement, as well as neurotechnology products, emergency-care equipment, and hospital beds and stretchers. Its sales depend heavily on the number of surgeries hospitals perform, so investors often treat it as a gauge of procedure volumes and of hospital spending on equipment.
Intuitive Surgical, maker of the da Vinci surgical robot, is likewise tied to hospital procedure volumes, and both are major players in surgical robotics.
Tools and devices beat pharma
Monday's health care trading split along clear lines. The sector as a whole was the weakest in the S&P 500 at midday and finished with a modest decline.
Big pharmaceutical companies weighed on it. Merck (NYSE:MRK) was the worst performer in the Dow. Bristol-Myers Squibb (NYSE:BMY) slid after Leerink Partners downgraded it, and Johnson & Johnson (NYSE:JNJ) and Pfizer (NYSE:PFE) also fell.
Life-science tools stocks went the other way. Charles River Laboratories (NYSE:CRL) climbed sharply to a 52-week high of $303.33 and was the second-best performer in the S&P 500. Thermo Fisher Scientific (NYSE:TMO) and Danaher (NYSE:DHR) rose, and Illumina (NASDAQ:ILMN) jumped.
Records for the Nasdaq
The broader market finished higher. The Nasdaq Composite rose 286.45 points to a record close of 27,477.31, and the Nasdaq-100 set a record at 31,076.44. The S&P 500 gained 51.23 points to 7,773.95, just shy of its summer record, and the Dow Jones Industrial Average added 90.94 points to 51,267.90. Advancing S&P 500 stocks outnumbered decliners by 1.7 to 1.
Bond markets told a more cautious story. The 10-year Treasury Yield rose to its highest close since 2002, and the ISM services survey showed prices paid at their highest since July 2022. Oxford Economics senior US economist Matthew Martin said: "The prices index continues to trend markedly higher."
At the same time, Friday's jobs report showed only 29,000 positions added in September, well below forecasts. That cut the odds of another Fed rate hike in October to roughly one in four or less, down from better than even a week earlier.
Oil eased, with Brent settling at $100.32 a barrel and US crude near $89.43, after G7 nations agreed to release 100 million barrels of crude and diesel from emergency reserves. The Strait of Hormuz remains effectively closed.
What to watch
For Stryker, the next big moment is its quarterly Earnings report, where investors will look for updates on surgical volumes and Demand for its robotic and implant products. Results from other device makers will also shape sentiment toward the group.
On the macro calendar, minutes from the Fed's September meeting are due on Wednesday, Oct. 7, at 2 p.m. ET. PepsiCo reports Thursday and Delta Air Lines Friday. Bank earnings start on Oct. 13, and the Fed's next policy meeting is Oct. 27–28.
_11_16_2026_14_38_45_453029.jpg)





Please wait processing your request...